Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4185 - 4192 of 12011 results
Part Two of the COVID-19 Roadmap Series: Creating a COVID-19 Operations Infrastructure
April 27, 2020| Blog| Viewpoint
USCIS Offices Planning to Reopen on or After June 4
April 27, 2020| Blog| Viewpoint
New York’s Department of Health Provides Guidance on Face Coverings for Essential Workers
April 25, 2020| Blog| Viewpoint
In Case You Missed It: COVID-19 Webinars to Keep You Informed
April 24, 2020| Blog| Viewpoint
"Fuss" Majeure: Lessons from the Early Outbreak of Covid v. Contract Cases
April 24, 2020| Blog| Viewpoint
Citrix Telemarketing Row Stayed For High Court TCPA Ruling
April 24, 2020| News
NYSE Temporarily Extends Compliance Periods for Certain Continued Listing Requirements as a Result of Coronavirus (COVID-19)
April 24, 2020| Advisory| Viewpoint
CBRS Alliance President, Lawyers Eye COVID-19 Impacts on Auction
April 24, 2020| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|